Exact Sciences Corporation
Exact Sciences Corporation (EXAS) Stock Overview
Explore Exact Sciences Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
8.6B
P/E Ratio
-8.62
EPS (TTM)
$-5.45
ROE
-0.38%
EXAS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Exact Sciences Corporation (EXAS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 44.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $54.16.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.62 and a market capitalization of 8.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.